Joel Greenblatt's position in Evolent Health is currently worth $1.2 Million. That's 0.02% of their equity portfolio (772nd largest holding). The first Evolent Health trade was made in Q2 2017. Since then Joel Greenblatt bought shares four more times and sold shares on two occasions. The investor's estimated purchase price is $1.66 Million, resulting in a loss of 28%.